2017 Q2 Form 10-Q Financial Statement

#000088250817000027 Filed on May 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $3.170M $2.950M
YoY Change 7.46% -40.68%
Cost Of Revenue $1.797M $1.794M
YoY Change 0.17% -36.61%
Gross Profit $1.373M $1.156M
YoY Change 18.77% -46.06%
Gross Profit Margin 43.31% 39.19%
Selling, General & Admin $2.414M $2.693M
YoY Change -10.36% 0.11%
% of Gross Profit 175.82% 232.96%
Research & Development $2.427M $3.447M
YoY Change -29.59% -1.32%
% of Gross Profit 176.77% 298.18%
Depreciation & Amortization $360.0K $310.0K
YoY Change 16.13% -13.89%
% of Gross Profit 26.22% 26.82%
Operating Expenses $4.841M $6.140M
YoY Change -21.16% -3.34%
Operating Profit -$3.468M -$4.984M
YoY Change -30.42% 18.41%
Interest Expense $61.00K $38.00K
YoY Change 60.53% 153.33%
% of Operating Profit
Other Income/Expense, Net $0.00 -$7.000K
YoY Change -100.0% -78.79%
Pretax Income -$3.529M -$5.029M
YoY Change -29.83% 18.13%
Income Tax $36.00K $64.00K
% Of Pretax Income
Net Earnings -$3.565M -$5.093M
YoY Change -30.0% 19.05%
Net Earnings / Revenue -112.46% -172.64%
Basic Earnings Per Share -$0.05 -$0.09
Diluted Earnings Per Share -$0.05 -$0.09
COMMON SHARES
Basic Shares Outstanding 68.79M shares 58.37M shares
Diluted Shares Outstanding 68.79M shares 58.37M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.70M $23.30M
YoY Change 14.59% -11.74%
Cash & Equivalents $26.67M $23.30M
Short-Term Investments
Other Short-Term Assets $141.0K $104.0K
YoY Change 35.58% -3.7%
Inventory $2.861M $3.330M
Prepaid Expenses $836.0K $1.076M
Receivables $1.807M $1.555M
Other Receivables $0.00 $0.00
Total Short-Term Assets $32.32M $29.37M
YoY Change 10.05% -7.9%
LONG-TERM ASSETS
Property, Plant & Equipment $2.566M $3.636M
YoY Change -29.43% 35.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $233.0K $229.0K
YoY Change 1.75% 0.0%
Total Long-Term Assets $2.799M $3.865M
YoY Change -27.58% 32.45%
TOTAL ASSETS
Total Short-Term Assets $32.32M $29.37M
Total Long-Term Assets $2.799M $3.865M
Total Assets $35.12M $33.23M
YoY Change 5.68% -4.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.500M $3.300M
YoY Change -24.24% 50.0%
Accrued Expenses $2.016M $1.828M
YoY Change 10.28% -11.65%
Deferred Revenue
YoY Change
Short-Term Debt $6.000M $0.00
YoY Change
Long-Term Debt Due $200.0K $300.0K
YoY Change -33.33% -75.0%
Total Short-Term Liabilities $11.00M $5.428M
YoY Change 102.69% -1.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $3.100M
YoY Change -100.0% 3000.0%
Other Long-Term Liabilities $45.00K $127.0K
YoY Change -64.57% -18.06%
Total Long-Term Liabilities $45.00K $127.0K
YoY Change -64.57% -18.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.00M $5.428M
Total Long-Term Liabilities $45.00K $127.0K
Total Liabilities $11.09M $8.686M
YoY Change 27.67% 51.11%
SHAREHOLDERS EQUITY
Retained Earnings -$243.5M -$225.8M
YoY Change 7.8% 7.13%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.03M $24.55M
YoY Change
Total Liabilities & Shareholders Equity $35.12M $33.23M
YoY Change 5.68% -4.52%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$3.565M -$5.093M
YoY Change -30.0% 19.05%
Depreciation, Depletion And Amortization $360.0K $310.0K
YoY Change 16.13% -13.89%
Cash From Operating Activities -$3.866M -$4.457M
YoY Change -13.26% 119.56%
INVESTING ACTIVITIES
Capital Expenditures $15.00K $1.051M
YoY Change -98.57% -1055.45%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$15.00K -$1.051M
YoY Change -98.57% 855.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $17.07M $10.00M
YoY Change 70.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $15.69M $9.674M
YoY Change 62.14% 2745.29%
NET CHANGE
Cash From Operating Activities -$3.866M -$4.457M
Cash From Investing Activities -$15.00K -$1.051M
Cash From Financing Activities $15.69M $9.674M
Net Change In Cash $11.80M $4.166M
YoY Change 183.34% -331.44%
FREE CASH FLOW
Cash From Operating Activities -$3.866M -$4.457M
Capital Expenditures $15.00K $1.051M
Free Cash Flow -$3.881M -$5.508M
YoY Change -29.54% 186.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Amendment Flag
AmendmentFlag
false
CY2017Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q2 dei Document Period End Date
DocumentPeriodEndDate
2017-04-02
CY2017Q2 dei Document Type
DocumentType
10-Q
CY2017Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000882508
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79561420 shares
CY2017Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q2 dei Entity Registrant Name
EntityRegistrantName
QUICKLOGIC CORPORATION
CY2016Q2 quik Purchase Of Equipment Included In Accounts Payable
PurchaseOfEquipmentIncludedInAccountsPayable
385000 USD
CY2017Q2 quik Purchase Of Equipment Included In Accounts Payable
PurchaseOfEquipmentIncludedInAccountsPayable
15000 USD
CY2016Q4 quik Shelf Registration Maximum Offering
ShelfRegistrationMaximumOffering
40000000.0 USD
CY2017Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2018000 USD
CY2017Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2498000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
839000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1807000 USD
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1580000 USD
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2016000 USD
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12132000 USD
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12484000 USD
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
251824000 USD
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
267419000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
562000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
318000 USD
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2017Q1 us-gaap Assets
Assets
21844000 USD
CY2017Q2 us-gaap Assets
Assets
35118000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
18849000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
32319000 USD
CY2017Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
209000 USD
CY2017Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
213000 USD
CY2017Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
209000 USD
CY2017Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
171000 USD
CY2016Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
414000 USD
CY2017Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
213000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3529000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000 USD
CY2017Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
0 USD
CY2017Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
42000 USD
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Executory Costs
CapitalLeasesFutureMinimumPaymentsExecutoryCosts
2000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19136000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23302000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14870000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26674000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4166000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11804000 USD
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2300000 shares
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68134000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79561000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68134000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79561000 shares
CY2017Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
68000 USD
CY2017Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
79000 USD
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1794000 USD
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1797000 USD
CY2017Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
6209000 USD
CY2017Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
6213000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
317000 USD
CY2016Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
312000 USD
CY2017Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
355000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1222000 USD
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1632000 USD
CY2016Q2 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
0 USD
CY2017Q2 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
70000 USD
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M28D
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
700000 USD
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
400000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
1156000 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
1373000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5029000 USD
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
455000 USD
CY2017Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
948000 USD
CY2016Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-240000 USD
CY2017Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-183000 USD
CY2016Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6000 USD
CY2017Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-414000 USD
CY2017Q2 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
267000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-46000 USD
CY2017Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
968000 USD
CY2016Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
348000 USD
CY2017Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
75000 USD
CY2016Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2017Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
317000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
38000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
61000 USD
CY2017Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
479000 USD
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
622000 USD
CY2017Q1 us-gaap Inventory Net
InventoryNet
2017000 USD
CY2017Q2 us-gaap Inventory Net
InventoryNet
2861000 USD
CY2017Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1538000 USD
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2239000 USD
CY2016Q2 us-gaap Inventory Write Down
InventoryWriteDown
3000 USD
CY2017Q2 us-gaap Inventory Write Down
InventoryWriteDown
104000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
9856000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
11089000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21844000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35118000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9807000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11002000 USD
CY2017Q1 us-gaap Line Of Credit
LineOfCredit
6000000 USD
CY2017Q2 us-gaap Line Of Credit
LineOfCredit
6000000 USD
CY2017Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
6000000 USD
CY2017Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
6000000 USD
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
0 USD
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
42000 USD
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6209000 USD
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6171000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9674000 USD
CY2017Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15685000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1051000 USD
CY2017Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4457000 USD
CY2017Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3866000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-5093000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-3565000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
6140000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
4841000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4984000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3468000 USD
CY2016Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
198000 USD
CY2017Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
211000 USD
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
358000 USD
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
384000 USD
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
163000 USD
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
141000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
233000 USD
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49000 USD
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2016Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1200000 USD
CY2017Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1242000 USD
CY2016Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
51000 USD
CY2017Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
20000 USD
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1051000 USD
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 USD
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2017Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1123000 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
977000 USD
CY2017Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
960000 USD
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
836000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8800000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15800000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15800000 USD
CY2016Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000000 USD
CY2017Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17069000 USD
CY2016Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1000000 USD
CY2017Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14897000 USD
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15050000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2765000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2566000 USD
CY2016Q2 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
75000 USD
CY2017Q2 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
122000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3447000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2427000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239904000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-243469000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
2950000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
3170000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2693000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2414000 USD
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
562000 USD
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
318000 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
101000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.00
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
136000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.70
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1370000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1353000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.68
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.68
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
52000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.72
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3976000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.61
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
27000 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
80000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1136000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4979000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4846000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.35
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.35
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
999000 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4685000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.39
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.31
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.01
CY2017Q2 us-gaap Share Price
SharePrice
1.78
CY2016Q1 us-gaap Share Price
SharePrice
1.00
CY2017Q1 us-gaap Share Price
SharePrice
1.50
CY2017Q1 us-gaap Share Price
SharePrice
1.50
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
449000 USD
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y8M27D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M17D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2016Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
53000 shares
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
11988000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
24029000 USD
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58371000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68794000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58371000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68794000 shares
CY2017Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risk</font></div><div style="line-height:120%;text-align:left;padding-left:14px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's accounts receivable are denominated in U.S. dollars and are derived primarily from sales to customers located in North America, Asia Pacific, and Europe. The Company performs ongoing credit evaluations of its customers and generally does not require collateral. See Note 11 for information regarding concentrations associated with accounts receivable.</font></div></div>
CY2017Q2 us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QuickLogic's fiscal year ends on the Sunday closest to December&#160;31 and the fiscal quarters each end on the Sunday closest to the end of each calendar quarter. QuickLogic's </font><font style="font-family:inherit;font-size:10pt;">first</font><font style="font-family:inherit;font-size:10pt;"> fiscal quarters for </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and for </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> ended on Sunday, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">April&#160;2, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">April&#160;3, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>
CY2017Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Uses of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Actual results could differ materially from those estimates, particularly in relation to revenue recognition, the allowance for doubtful accounts, sales returns, valuation of investments, valuation of long-lived assets including mask sets, valuation of inventories including identification of excess quantities, market value and obsolescence, measurement of stock-based compensation awards, accounting for income taxes and estimating accrued liabilities.</font></div></div>

Files In Submission

Name View Source Status
0000882508-17-000027-index-headers.html Edgar Link pending
0000882508-17-000027-index.html Edgar Link pending
0000882508-17-000027.txt Edgar Link pending
0000882508-17-000027-xbrl.zip Edgar Link pending
a2009esppplanamendedex102.htm Edgar Link pending
a2009stockplanamendedex101.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
quik-20170402.xml Edgar Link completed
quik-20170402.xsd Edgar Link pending
quik-20170402_cal.xml Edgar Link unprocessable
quik-20170402_def.xml Edgar Link unprocessable
quik-20170402_lab.xml Edgar Link unprocessable
quik-20170402_pre.xml Edgar Link unprocessable
quik_2017xq1x10q.htm Edgar Link pending
quik_2017xq1x10qex31.htm Edgar Link pending
quik_2017xq1x10qex311.htm Edgar Link pending
quik_2017xq1x10qex312.htm Edgar Link pending
quik_2017xq1x10qex321.htm Edgar Link pending
quik_2017xq1x10qex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending